Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2006-11-27
2010-11-09
Flood, Michele (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
C514S894000
Reexamination Certificate
active
07829124
ABSTRACT:
The disclosure relates to a method of inhibiting synthesis of viral DNA in a mammal infected with a hepatitis B virus. This method includes administering at least onePhyllanthuscomponent or substance to a mammal infected with the hepatitis B virus. It also includes inhibiting hepatitis B viral DNA synthesis in the mammal using thePhyllanthuscomponent or substance. The disclosure also relates to a method of inhibiting viral gene expression in a mammal infected with a hepatitis B virus. This method includes administering at least onePhyllanthuscomponent or substance to a mammal infected with the hepatitis B virus. It also includes inhibiting expression of at least one hepatitis B viral gene in the mammal using thePhyllanthuscomponent or substance. These methods may form part of a method of preventing or treating hepatitis B infection.
REFERENCES:
patent: 28754 (1904-02-01), Von Keudell et al.
patent: 33275 (1904-02-01), Kreuter et al.
patent: 161477 (1904-08-01), Wagner et al.
patent: 4388457 (1983-06-01), Pettit
patent: 4673575 (1987-06-01), Venkateswaran et al.
patent: 4937074 (1990-06-01), Venkateswaran et al.
patent: 5529778 (1996-06-01), Rohatgi
patent: 5571441 (1996-11-01), Andon et al.
patent: 5648089 (1997-07-01), Shawkat
patent: 5854233 (1998-12-01), McLean
patent: 6136316 (2000-10-01), Mehrotra et al.
patent: 6258831 (2001-07-01), Camden
patent: 6586015 (2003-07-01), Gebhardt et al.
patent: 2002/0054921 (2002-05-01), Von Keudell et al.
patent: 8909059 (1989-10-01), None
patent: 9004968 (1990-05-01), None
patent: 0061161 (2000-09-01), None
Dusheiko, Treatment and Prevention of Chronic Viral Hepatitis, 1995, Pharmac. Ther., 65, 47-73.
Ono-Nita et al., YMDD Motif in Hepatitis B Virus DNA Polymerase Influences on Replication and Lamivudine Resistance: A Study by In Vitro Full-Length Viral DNA Transfection, 1999, 29, 939-945.
Thyagarajan et al., “Effect of Phyllanthus Amarus on Chronic Carriers of Hepatitis B Virus,”The Lancet, Oct. 1, 1988, pp. 764-766.
Venkateswaran et al., “Effects of an extract fromPhyllanthus nirurion hepatitis B and woodchuck hepatitis viruses: In vitro and in vivo studies,”Proc. Natl. Acad. Sci. USA, vol. 84, pp. 274-278, Jan. 1987.
Thyagarajan et al., “In vitro inactivation of HBsAg byEclipta albaHassk andPhyllanthus niruriLinn,”Indian J Med Res76 (Suppl), pp. 124-130, Dec. 1982.
Syamasundar et al., “Antihepatotoxic principles ofPhyllanthus niruriherbs,”J Ethnopharmacol14(1):41-4 Sep. 1985. Abstract only from National Library of Medicine: IGM Full Record Screen.
del Barrio Alonso et al., “The in-vitro inactivation of HBsAg by extracts of plants in the genusPhyllanthus,” Rev Cubana Med Trop., 47(2):127-130, 1995. Abstract only from National Library of Medicine: IGM Full Record Screen.
Doshi et al., “A two-stage clinical trial ofPhyllanthus amarusin hepatitis B carriers: failure to eradicate the surface antigen,”Indian J Gastroenterol., 13(1):7-8, 1994. Abstract only from National Library of Medicine: IGM Full Record Screen.
el-Mekkway et al., “Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase,”Chem Pharm Bull(Tokyo), 43(4):641-8, 1995. Abstract only from National Library of Medicine: IGM Full Record Screen.
Wang et al., “Herbs of the genusPhyllanthusin the treatment of chronic hepatitis B: observations with three preparations from different geographic sites,”J Lab Clin Med., 126(4):350-2, Oct. 1995. Abstract from National Library of Medicine: IGM Full Record Screen.
Wang et al., “Efficacy ofPhyllanthusspp. in treating patients with chronic hepatitis B,”Chung Kuo Chung Yao Tsa Chih., 19(12):750-1, 764, 1994. Abstract only from National Library of Medicine: IGM Full Record Screen.
Powis et al., “High-performance liquid chromatographic assay for the antitumor glycoside phyllanthoside and its stability in plasma of several species,”J Chromatogr, 342(1):129-34, Jul. 12, 1985. Abstract only from National Library of Medicine: IGM Full Record Screen.
Zhou Shiwen Xu Chuanfu et al., “Mechanism of protective action ofPhyllanthus urinariaL. against injuries of liver cells,”Zhongguo Zhongyao Zazhi, 22(2):109-111,129; 1997. Abstract only from Datenbank BIOSIS bei STN:AN 1997:211857 BIOSIS, DN PREV 199799511060.
Asha et al., “Preliminary evaluation of the antihepatotoxic activity ofPhyllanthus kozhikodianus, P. maderaspatensisandSolanum indicum,” Fitoterapia, 69(3):255-259, 1998. Abstract only from Database Biosis ′Online! Biosciences Information Service, Philadelphia, PA, US; 1998.
Jeena et al., “Effect ofEmblica officinalis, Phyllanthus amarusandPicrorrhiza kurroaon N-nitrosodiethylamine induced hepatocarcinogenesis,”Cancer Letters, 136(1):11-16, 1999. Abstract only from Database Biosis ′Online! Biosciences Information Service, Philadelphia, PA, US; Feb. 8, 1999.
Hu et al., “Process for preparing Gynostemma pentaphylla throat-moistening tablets—useful for treating bronchitis, asthma, and cancer.” Abstract onlyfrom Chemical Patents Index, Documentation Abstracts Journal Derwent Publications, London: 19.3.99,Nr.99-081999/08 zu: CN 1194857-A, Oct. 15, 2005.
S. Jayaram et a., Indian J. Virol. Vo. 13, No. 1, pp. 59-64 Efficacy ofPhyllanthus amarusTreatment in Acute Viral Hepatitis A,B and Non A Non B: An Open Clinical Trail (Jan. 1997).
P. Ferenci Gut 1993; supplement: S69-S73 Historical Treatment of Chronic Hepatitis B and Chronic Hepatitis C.
Steven P. Lawrence, M.D., Advances in Internal Medicine, vol. 45 2000 Mosby, Inc., Advances in the treatment of hepatitis C, Oct. 15, 2005.
Nippon Mektron KK (assignee), “Lipid metabolism improving and liver disturbance inhibitory agents—comprise organic solvent or water extract of Euphorbiaceae family,Phyllanthus niruri.” Abstract only from Chemical Patents Index, Documentation Abstracts Journal Derwent Publications, London: 19.12.97,Nr.97-508797/47 zu: JP 09241176 A, Oct. 15, 2005.
Hou et al., “SOD prepared fromPhyllanthus emblicaused as health food additive.” Abstract only from Chemical Patents Index, Documentation Abstracts Journal Derwent Publications, London: 12.12.97,Nr.97-490386/46 zu: CN 1121783 A, Oct. 15, 2005.
Mikimoto Seiyaku KK (assignee), “Cosmetic material having good skin-moisturising effect—consists of compounded mixt. of cholesteric liq. crystal and one or more of e.g.Piper longum, P. chabaetc.” Abstract only from Chemical Patents Index, Documentation Abstracts Journal Derwent Publications, London: 29.9.95,Nr.95-252224/33 zu: JP 07157420 A, Oct. 15, 2005.
Mikimoto Seiyaku KK (assignee), “Antioxidants used in lotions, creams and emulsions—contain solvent extract from e.g.Nigella savia, Munronia pumilaorBorrelia hispida.” Abstract only from Chemical Patents Index, Documentation Abstracts Journal Derwent Publications, London: 8.9.95,Nr.95-228590/30 zu: JP 07138126 A, Oct. 15, 2005.
Cao et al., “Antioxidant for cosmetic products.” Abstract only from Chemical Patents Index, Documentation Abstracts Journal Derwent Publications, London: 8.9.95,Nr.95-224715/30 zu: CN 1086532 A, Oct. 15, 2005.
Xiao et al., “Extraction ofPhyllanthus emblicapolysaccharides (PePS) and its scavenging effect on oxygen radical,”Zhongguo Yaoxue Zazhi(Beijing), 33(5):279-281, 1998. Abstract from Chemical Abstracts 130:452b.
Joy et al., “Inhibition ofPhyllanthus amarusof hepatocarcinogenesis induced by N-nitrosodiethylamine,”Journal of Clinical Biochemistry and Nutrition, 24(3):133-139, 1998. Abstract only from Datenbank BIOSIS bei STN:AN 1999:13953 BIOSIS, DN PREV 199900013953.
Potturi et al., “Protective effect ofPhyllanthus fraternusagainst thioacetamide-induced mitochondrial dysfunction,”Journal of Clinical Biochemistry and Nutrition, 22(2):113-123, 1997. Abstract only from Datenbank BIOSIS bei STN:AN 1997:4431146 BIOSIS, DN PREV 1997997423
Manns Michael P.
Ott Michael
Baker & Botts L.L.P.
Chen Catheryne
Flood Michele
LandOfFree
Use of Phyllanthus constituents for treating or preventing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of Phyllanthus constituents for treating or preventing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of Phyllanthus constituents for treating or preventing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4245839